Cloete Jeané, Kruger Annelet, Masha Maureen, du Plessis Nicolette M, Mawela Dini, Tshukudu Mphailele, Manyane Tabea, Komane Lekwetji, Venter Marietjie, Jassat Waasila, Goga Ameena, Feucht Ute
Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa; Centre for Maternal, Fetal, Newborn and Child Health Care Strategies, University of Pretoria, Pretoria, South Africa; Maternal and Infant Health Care Strategies Research Unit, South African Medical Research Council, Pretoria, South Africa.
Centre for Maternal, Fetal, Newborn and Child Health Care Strategies, University of Pretoria, Pretoria, South Africa; Department of Family Medicine, University of Pretoria, Pretoria, South Africa; Maternal and Infant Health Care Strategies Research Unit, South African Medical Research Council, Pretoria, South Africa; Tshwane District Health Services, Gauteng Department of Health, Pretoria, South Africa.
Lancet Child Adolesc Health. 2022 May;6(5):294-302. doi: 10.1016/S2352-4642(22)00027-X. Epub 2022 Feb 18.
South Africa reported a notable increase in COVID-19 cases from mid-November, 2021, onwards, starting in Tshwane District, which coincided with the rapid community spread of the SARS-CoV-2 omicron (B.1.1.529) variant. This increased infection rate coincided with a rapid increase in paediatric COVID-19-associated admissions to hospital (hereafter referred to as hospitalisations).
The Tshwane Maternal-Child COVID-19 study is a multicentre observational study in which we investigated the clinical manifestations and outcomes of paediatric patients (aged ≤19 years) who had tested positive for SARS-CoV-2 and were admitted to hospital for any reason in Tshwane District during a 6-week period at the beginning of the fourth wave of the COVID-19 epidemic in South Africa. We used five data sources, which were: (1) COVID-19 line lists; (2) collated SARS-CoV-2 testing data; (3) SARS-CoV-2 genomic sequencing data; (4) COVID-19 hospitalisation surveillance; and (5) clinical data of public sector COVID-19-associated hospitalisations among children aged 13 years and younger.
Between Oct 31 and Dec 11, 2021, 6287 children and adolescents in Tshwane District were recorded as having COVID-19. During this period, 2550 people with COVID-19 were hospitalised, of whom 462 (18%) were aged 19 years or younger. The number of paediatric cases was higher than in the three previous SARS-CoV-2 waves, uncharacteristically increasing ahead of adult hospitalisations. 75 viral samples from adults and children in the district were sequenced, of which 74 (99%) were of the omicron variant. Detailed clinical notes were available for 138 (75%) of 183 children aged ≤13 years with COVID-19 who were hospitalised. 87 (63%) of 138 children were aged 0-4 years. In 61 (44%) of 138 cases COVID-19 was the primary diagnosis, among whom symptoms included fever (37 [61%] of 61), cough (35 [57%]), shortness of breath (19 [31%]), seizures (19 [31%]), vomiting (16 [26%]), and diarrhoea (15 [25%]). Median length of hospital stay was 2 days [IQR 1-3]). 122 (88%) of 138 children with available data needed standard ward care and 27 (20%) needed oxygen therapy. Seven (5%) of 138 children were ventilated and four (3%) died during the study period, all related to complex underlying copathologies. All children and 77 (92%) of 84 parents or guardians with available data were unvaccinated to COVID-19.
Rapid increases in paediatric COVID-19 cases and hospitalisations mirror high community transmission of the SARS-CoV-2 omicron variant in Tshwane District, South Africa. Continued monitoring is needed to understand the long-term effect of the omicron variant on children and adolescents.
South African Medical Research Council, South African Department of Science & Innovation, G7 Global Health Fund.
南非报告称,自2021年11月中旬起,新冠肺炎病例数显著增加,最初出现在茨瓦内区,这与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎(B.1.1.529)变种在社区的快速传播相吻合。这种感染率的上升与儿科新冠肺炎相关住院病例(以下简称住院病例)的迅速增加同时出现。
茨瓦内母婴新冠肺炎研究是一项多中心观察性研究,我们调查了在南非新冠肺炎疫情第四波开始时的6周内,茨瓦内区因任何原因入院且SARS-CoV-2检测呈阳性的儿科患者(年龄≤19岁)的临床表现和结局。我们使用了五个数据源,分别是:(1)新冠肺炎病例清单;(2)整理后的SARS-CoV-2检测数据;(3)SARS-CoV-2基因组测序数据;(4)新冠肺炎住院监测;(5)13岁及以下儿童公共部门新冠肺炎相关住院病例的临床数据。
2021年10月31日至12月11日期间,茨瓦内区有6287名儿童和青少年被记录为感染了新冠肺炎。在此期间,2550名新冠肺炎患者住院,其中462人(18%)年龄在19岁及以下。儿科病例数高于之前的三波SARS-CoV-2疫情,且异常地在成人住院病例之前增加。对该地区75份成人和儿童的病毒样本进行了测序,其中74份(99%)为奥密克戎变种。有138名年龄≤13岁的新冠肺炎住院儿童的详细临床记录可供使用(占183名此类儿童的75%)。138名儿童中有87名(63%)年龄在0至4岁。在138例病例中的61例(44%)中,新冠肺炎是主要诊断,其中症状包括发热(61例中的37例[61%])、咳嗽(35例[57%])、呼吸急促(19例[31%])、惊厥(19例[31%])、呕吐(16例[26%])和腹泻(15例[25%])。住院中位时长为2天[四分位间距1 - 3天])。138名有可用数据的儿童中有122名(88%)需要标准病房护理,27名(20%)需要氧疗。138名儿童中有7名(5%)接受了通气治疗,4名(3%)在研究期间死亡,均与复杂的基础合并症有关。所有儿童以及84名有可用数据的父母或监护人中的77名(92%)均未接种新冠肺炎疫苗。
儿科新冠肺炎病例和住院病例的迅速增加反映了南非茨瓦内区SARS-CoV-2奥密克戎变种在社区的高传播率。需要持续监测以了解奥密克戎变种对儿童和青少年的长期影响。
南非医学研究理事会、南非科学与创新部、七国集团全球卫生基金。